ZyVersa's IC 100 Shows Promise as Disease-Modifying Treatment for Parkinson's Disease
New research validates that microglia-driven inflammation plays a pivotal role in Parkinson's disease progression, with studies showing IC 100 can block NLRP1 inflammasome activation and reduce toxic alpha-synuclein accumulation.
Novel Research Reveals UCHL1 as Therapeutic Target in Ovarian Cancer and Western Diet's Impact on Liver Cancer
Research at the OncLive National Fellows Forum demonstrates UCHL1 inhibition shows promise as a therapeutic target in high-grade serous ovarian cancer, with varying effects based on chemotherapy resistance status.
Gene Editing Shows Promise for Treating Autosomal Dominant Hearing Loss
Researchers are utilizing a $16 million NIH grant to explore AAV-mediated gene editing for autosomal dominant hearing loss.
Schwann Cell Therapy Aids Paralysis Recovery, Inspires Patient's Medical Career
Annalisa Heiss, injured in a car accident, regained motor function in her leg through an innovative clinical trial involving Schwann cell transplantation.
Hyperbaric Oxygen Therapy Evaluated for Ulcerative Colitis Treatment in Clinical Trial
A clinical trial is underway at the University of Miami Miller School of Medicine, among 15 sites, to assess hyperbaric oxygen therapy (HBOT) for ulcerative colitis treatment.